EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Intraperitoneal drug delivery systems for peritoneal carcinomatosis: Bridging the gap between research and clinical implementation

M Teresa Perelló-Trias, Antonio Jose Serrano-Muñoz, Ana Rodríguez-Fernández, Juan José Segura-Sampedro, Joana Maria Ramis, Marta Monjo

Journal of Controlled Release · 2024-09 · 373 · 70-92

DOI: 10.1016/j.jconrel.2024.07.017 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Controlled Release, 2024-09. Verfasst von M Teresa Perelló-Trias und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cell Therapy and Tissue Engineering Group (TERCIT), Research Institute of Health Sciences (IUNICS), University of the Balearic Islands (UIB), Carrete…. Hauptthemen laut MEDLINE: Peritoneal Neoplasms, Drug Delivery Systems, Antineoplastic Agents. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 151 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Several abdominal-located cancers develop metastasis within the peritoneum, what is called peritoneal carcinomatosis (PC), constituting a clinical challenge in their therapeutical management, often leading to poor prognoses. Current multidisciplinary strategies, including cytoreductive surgery (CRS), hyperthermic intraperitoneal chemotherapy (HIPEC), and pressurized intraperitoneal aerosol chemotherapy (PIPAC), demonstrate efficacy but have limitations. In response, alternative strategies are explored in the drug delivery field for intraperitoneal chemotherapy. Controlled drug delivery offers a promising avenue, maintaining localized drug concentrations for optimal PC management. Drug delivery systems (DDS), including hydrogels, implants, nanoparticles, and hybrid systems, show potential for sustained and region-specific drug release. The present review aims to offer an overview of the advances and current designs of DDS for PC chemotherapy administration, focusing on their composition, main characteristics, and principal experimental outcomes, highlighting the importance of biomaterial rationale design and in vitro/vivo models for their testing. Moreover, since clinical data for human subjects are scarce, we offer a critical discussion of the gap between bench and bedside in DDS translation, emphasizing the need for further research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peritoneal NeoplasmsDrug Delivery SystemsAntineoplastic AgentsHumansAnimals

Stichwörter der Autor:innen

BiomaterialsDrug delivery systemsIntraperitoneal chemotherapyPeritoneal carcinomatosis

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Cell Therapy and Tissue Engineering Group (TERCIT), Research Institute of Health Sciences (IUNICS), University of the Balearic Islands (UIB), Carretera de Valldemossa, Km 7,5, 07122 Palma, Balearic Islands, Spain; Healt…
  • Health Research Institute of the Balearic Islands (IdISBa) - Carretera de Valldemossa, 79. Hospital Universitari Son Espases. Edifici S. 07120 Palma, Balearic Islands, Spain; General & Digestive Surgery Service, Hospita…

Zitieren

APA

Perelló-Trias, M. T., Serrano-Muñoz, A. J., Rodríguez-Fernández, A., Segura-Sampedro, J. J., Ramis, J. M., & Monjo, M. (2024). Intraperitoneal drug delivery systems for peritoneal carcinomatosis: Bridging the gap between research and clinical implementation. Journal of Controlled Release, 373, 70-92. https://doi.org/10.1016/j.jconrel.2024.07.017

Vancouver

Perelló-Trias MT, Serrano-Muñoz AJ, Rodríguez-Fernández A, Segura-Sampedro JJ, Ramis JM, Monjo M. Intraperitoneal drug delivery systems for peritoneal carcinomatosis: Bridging the gap between research and clinical implementation. Journal of Controlled Release. 2024;373:70-92. doi:10.1016/j.jconrel.2024.07.017

BibTeX
@article{PerellTrias2024,
  author = {Perelló-Trias, M Teresa and Serrano-Muñoz, Antonio Jose and Rodríguez-Fernández, Ana and Segura-Sampedro, Juan José and Ramis, Joana Maria and Monjo, Marta},
  title = {Intraperitoneal drug delivery systems for peritoneal carcinomatosis: Bridging the gap between research and clinical implementation},
  journal = {Journal of Controlled Release},
  year = {2024},
  volume = {373},
  pages = {70--92},
  doi = {10.1016/j.jconrel.2024.07.017}
}
Kostenlos starten →